Alexion Pharmaceuticals Inc. (ALXN) is in the Pharma Industry

• Sort by
• View by Content Type
• View Related Content by Tag

• 5 Potential Buyout Targets in Biotech - Barron's

  Bristol-Myers Squibb BMY made a $4.5B bid for the shares of ImClone IMCL it doesn't already own. Roche Holdings (RHHBY.PK) made a $44B offer for the shares of Genetech DNA it doesn't own. Both targets want the bid prices raised. Barron's Lawrence Strauss says these are just the two latest...

  External links 2008-08-17

  Tags: Biotech, Alexion Pharmaceuticals Inc., Amylin Pharmaceuticals Inc., Bristol-Myers Squibb Co., Genentech Inc., ImClone Systems Inc., Eli Lilly & Co., Merck & Co. Inc., Onyx Pharmaceuticals Inc., Pfizer Inc., United Therapeutics Corp., Vertex Pharmaceuticals Inc., Wyeth

• Alexion Pharmaceuticals, Inc. Q2 2008 Earnings Call

  Alexion Pharmaceuticals, Inc. ALXN Q2 FY08 Earnings Call

  Earnings calls 2008-07-29

  Tags: Alexion Pharmaceuticals Inc., Earnings, Seeking Alpha, Financial Accounting, Finance

• Alexion Pharmaceuticals, Inc. Q1 2008 Earnings Call Transcript

  Alexion Pharmaceuticals, Inc. Q1 2008 Earnings Call Transcript

  Earnings calls 2008-04-30

  Tags: Call Transcript, Earnings, Seeking Alpha, Financial Accounting, Finance, Alexion Pharmaceuticals Inc.

• Alexion Pharmaceuticals, Inc. Q4 2007 Earnings Call Transcript

  Alexion Pharmaceuticals, Inc. Q4 2007 Earnings Call Transcript

  Earnings calls 2008-02-14

  Tags: Alexion Pharmaceuticals Inc., Call Transcript, Earnings, Seeking Alpha, Financial Accounting, Finance

Additional Resources

• BellwetherReport.com Analyst Report on EVVV, BEAV, ELNK and ALXN

  BellwetherReport.com is the leading onlinefinancial newsletter for investors seeking top independent and unbiasedresearch. Investors seeking free and unbiased analyst opinions on thecompanies mentioned in this release are encouraged to sign up to www.bellwetherreport.com for a free subscription to access these reports.Today, we have once again scheduled interviews with a...

  Articles 2008-07-29

• InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria

  SAN FRANCISCO, July 23 /PRNewswire/ -- InCode BioPharmaceutics, Inc., an emerging biopharmaceutical company, today announced preclinical test results demonstrating the utility of their lead drug candidate rC3-1 for the treatment of the rare chronic blood disorder paroxysmal nocturnal hemoglobinuria PNH. The complete results will be presented at the XXII...

  Articles 2008-07-23

• Zacks Analyst Blog Highlights: Corel Corporation, Alexion Pharmaceuticals, Proctor & Gamble, Lexicon Pharmaceuticals Inc. and American Public Education, Inc

  CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Corel Corporation (Nasdaq: CREL), Alexion Pharmaceuticals (Nasdaq: ALXN),...

  Articles 2008-07-09

• Alexion to Present at the Jefferies & Co. 2nd Annual Healthcare Conference

  CHESHIRE, Conn., June 18 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. today announced that Dr. Leonard Bell, Chief Executive Officer of Alexion Pharmaceuticals, will present at the Jefferies & Co. 2nd Annual Healthcare Conference in New York City at 4:15 p.m., ET on Wednesday, June 25, 2008....

  Articles 2008-06-18

• Mergent, Inc. Announces Quarterly Rebalancing of HealthShares™ Indexes

  NEW YORK, June 17 /PRNewswire/ -- Mergent, Inc., administrator for the HealthSharesTM Indexes, a series of 20 underlying indexes for the HealthSharesTM Exchange Traded Funds, today announced the quarterly rebalancing of the Indexes. The following securities will be added and deleted in the Indexes effective before...

  Articles 2008-06-17

• Soliris® Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis

  Data Suggest Role of Hemolysis in PNH-Related Fatigue Presentation at the European Hematology Association 13th Congress CHESHIRE, Conn., June 15 /PRNewswire-FirstCall/ -- SolirisR eculizumab therapy improved the often disabling fatigue experienced by patients with the rare blood disorder paroxysmal nocturnal hemoglobinuria PNH...

  Articles 2008-06-15

• Alexion to Present at the William Blair 28th Annual Growth Stock Conference

  CHESHIRE, Conn., June 13 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. today announced that Vikas Sinha, Senior Vice President and Chief Financial Officer of Alexion Pharmaceuticals, will present at the William Blair 28th Annual Growth Stock Conference in Chicago at 9:10 a.m., local time (10:10 a.m., eastern)...

  Articles 2008-06-13

• CytRx Corporation Signs Definitive Agreement to Acquire Innovive Pharmaceuticals, Inc

  Combined Company to Drive Stockholder Value with Commitment to Molecular Chaperone Technology Platform and Near-Term Commercialization Opportunities in Oncology Acquisition Subject to Customary Closing Conditions Including Innovive Stockholder Approval Company to Host Conference Call at 9:00 AM EDT (6:00 AM PDT) Today to...

  Articles 2008-06-09

• Alexion to Present at the Goldman Sachs 29th Annual Global Healthcare Conference

  CHESHIRE, Conn., June 5 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. today announced that Dr. Leonard Bell, Chief Executive Officer of Alexion Pharmaceuticals, will present at the Goldman Sachs 29th Annual Global Healthcare Conference in Laguna Niguel, CA at 8:00 a.m., local time (11:00 a.m., eastern) on...

  Articles 2008-06-05

• Alexion to Present at Citi's 2008 Healthcare Conference

  CHESHIRE, Conn., May 14 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. today announced that Dr. Leonard Bell, Chief Executive Officer of Alexion Pharmaceuticals, will present at Citi's 2008 Healthcare Conference in New York City at 4:00 p.m. ET on Wednesday, May 21, 2008. An audio webcast of Dr....

  Articles 2008-05-14

• Notice of Time Change for Alexion's Presentation at the Bank of America 2008 Health Care Conference

  CHESHIRE, Conn., May 9 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. today announced that the time of Alexion's presentation at the Bank of America 2008 Health Care Conference in Las Vegas has been changed to 4:00 p.m., local time (7:00 p.m., eastern) on Tuesday, May 13, 2008. Vikas Sinha,...

  Articles 2008-05-09

• Alexion to Present at the Bank of America 2008 Health Care Conference

  CHESHIRE, Conn., May 6 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. today announced that Vikas Sinha, Senior Vice President and Chief Financial Officer of Alexion Pharmaceuticals, will present at the Bank of America 2008 Health Care Conference in Las Vegas at 4:40 p.m., local time (7:40 p.m., eastern) on Tuesday,...

  Articles 2008-05-06

• Alexion Pharmaceutical Hopes the Fourth Time Is a Charm for Smithfield Site, an Industrial Info News Alert

  Reported by Annette Kreuger, Industrial InfoResources (Sugar Land, Texas) -- The most recent incarnation of the formerDowpharma (NYSE:DOW) (Midland, Michigan) plant in Smithfield, RhodeIsland, is now complete. Alexion Pharmaceuticals (NASDAQ:ALXN) (Cheshire,Connecticut) has made a capital investment of $80 million into renovatingthe 60,000-square-foot plant for the production of its blood disorder...

  Articles 2008-04-14

• Zacks Analyst Blog Highlights: Oplink Communications, Tellabs, Comtech Group, Terex Corp. and Alexion Pharma

  CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Oplink Communications Inc. (Nasdaq: OPLK), Tellabs Inc. (Nasdaq: TLAB), Comtech Group,...

  Articles 2008-04-10

• Alexion Pharmaceuticals Inc. Review in Progress.

  M2 PRESSWIRE-20 March 2008-The Maybach Review: Alexion Pharmaceuticals Inc. Review in ProgressC1994-2008 M2 COMMUNICATIONS LTD RDATE:20032008 MaybachFinancial.com is one of the fastest growing independent and unbiased research firms in the world. Investors wanting to know the truth about...

  Articles 2008-03-20

• Alexion to Present at Investor Conferences

  CHESHIRE, Conn., March 11 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. today announced that Leonard Bell, M.D., Chief Executive Officer of Alexion Pharmaceuticals, will present at two upcoming investor conferences, one sponsored by Cowen and Company and the other by Lehman Brothers. Dr. Bell will present at the...

  Articles 2008-03-11